triple hormone receptor agonist retatrutide Original Article: Triple–Hormone-Receptor for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #ADA23 retatrutide investigational drug triple hormone
Description
22 The relationship between insulin resistance and MASLD has not been fully elucidated, but potential mechanisms that promote MASLD/MASH include influencing hepatic lipid synthesis and catabolism, as well as impairing mitochondrial fatty acid -oxidation function
Effects of Retatrutide on glucose metabolism in type 2 diabetes. Diabetes Care , 46(12), 2819-2831
Hayward, and E
EMA: European Medicines Agency
It provides an easy, low-barrier alternative
